G A Edelstyn. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Age FactorsBone Neoplasms/drug therapyBreast Neoplasms/drug therapyFemaleGastrointestinal Neoplasms/drug therapyHumansNeoplasm MetastasisNorethindrone/administration & dosageNorethindrone/therapeutic useRemission, SpontaneousTime Factors
Substances: See more » Norethindrone
Year: 1973 PMID: 4757921 DOI: 10.1002/1097-0142(197312)32:6<1317::aid-cncr2820320604>3.0.co;2-a
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860